HealthRX vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 3, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Hers scores higher on our rubric, 5.3/10 against 5.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Hers - our pick of these two →or find your match

Hers beats HealthRX overall, scoring 5.3/10 vs 5.2/10. Published pricing is not a like-for-like monthly comparison: HealthRX is from $99/mo; Hers is $188 first month, then $298/mo. Choose HealthRX for cash-pay patients who want low flat-dose compounded glp-1 pricing, all-50-state access, fast shipping, and self-service cancellation. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.

A side-by-side look at HealthRX and Hers to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

HealthRX

#47 of 54

5.2/10

HealthRX is a cash-pay telehealth platform for compounded injectable semaglutide and tirzepatide. Its pricing page publishes eight plans: semaglutide at $190 month to month, $133/mo on 3 months, $119/mo on 6 months and $99/mo on 12 months, and tirzepatide at $239, $209, $199 and $179 on the same terms. Prices stay flat across doses and include clinician review, dose adjustments and overnight shipping, and the site promises a full refund if a provider does not approve you. Prescriptions come from independent US-licensed clinicians, and neither a clinician network nor the dispensing 503A pharmacy is named on the site's about, how it works, FAQ or terms pages (rendered check 2026-09-03).

Visit HealthRX

Higher Rated

Hers

#44 of 54

5.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers

Feature	HealthRX	Hers
Why each one	Low flat-dose pricing paired with linked LegitScript verification, nationwide clinician coverage, overnight shipping, and self-service account cancellation.	A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.
Our Score	5.2/10	5.3/10
Headline Price	from $99/mo	$188 first month, then $298/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Cash-pay patients who want low flat-dose compounded GLP-1 pricing, all-50-state access, fast shipping, and self-service cancellation	Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path
Watch out for	The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site	Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
Ranking	#47	#44
Get started	Visit HealthRX	Visit Hers

Pros & Cons Compared

HealthRX

Pros

+$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
+Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
+Independent US-licensed clinicians in all 50 states, with the homepage saying a board-certified physician reviews your file within 24 hours
+Full refund if a provider does not approve you, stated on the homepage, the pricing page and the terms
+LegitScript certificate 50087439 links to the issuer's verification checker
+Single-click account cancellation and refunds for unshipped doses
+Published HIPAA notice, telehealth consent, safety information, and emergency instructions

Cons

−The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
−Legal entity, headquarters, executive team, and medical director remain undisclosed
−The $99/mo semaglutide headline needs $1,188 paid up front for a full year. Buying month to month costs $190 on its pricing page, verified 2026-09-03
−The 4.8/5 from 12,000+ members block uses illustrative composites rather than an independent review platform
−Cash-pay only, with no insurance billing or prior-authorization support
−Compounded medications sit outside FDA premarket approval as finished products

Hers

Pros

+Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

−Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
−Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
−Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
−Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
−Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

Our Verdict

Hers edges out HealthRX with a score of 5.3/10 vs 5.2/10. Published pricing is not a like-for-like monthly comparison: HealthRX is from $99/mo; Hers is $188 first month, then $298/mo. Hers offers both brand-name and compounded medications, giving you more flexibility.